Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the healthcare sector, particularly within the dynamic field of biotechnology. With a market capitalization of $1.23 billion, this Cambridge, Massachusetts-based..
Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical stage biotechnology company, is making waves in the healthcare sector with its innovative therapies targeting inflammatory bowel diseases (IBD) such as ulcerative colitis..
Investors seeking exposure to the healthcare sector, particularly in the diagnostics and research industry, may find Fulgent Genetics, Inc. (NASDAQ: FLGT) an intriguing opportunity. With a market capitalization of approximately..
CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, is drawing significant attention from investors with its substantial potential upside of 147.97%. As..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing attention in the biotech sector with its significant potential upside, as highlighted by recent analyst ratings. Based in New Haven, Connecticut, Trevi Therapeutics..
HealthStream, Inc. (NASDAQ: HSTM) is capturing the attention of investors with its promising potential upside of 27.59%, according to the latest analyst consensus. As a key player in the healthcare..
Vir Biotechnology, Inc. (NASDAQ: VIR) is a compelling case for investors with a keen eye on the biotechnology sector. Despite facing significant revenue challenges, the company presents an intriguing potential..
In the ever-evolving world of biotechnology, LENZ Therapeutics, Inc. (NASDAQ: LENZ) stands out as a compelling story for investors. With a market capitalization of $973.01 million, this Solana Beach, California-based..
Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the healthcare sector, is capturing investor attention with a significant potential upside of 78.93%. The company’s pioneering work in the medical..
Investors interested in the biotechnology sector are increasingly turning their attention to uniQure N.V. (NASDAQ: QURE), a trailblazer in the development of gene therapies for rare diseases. With a market..
Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector, specializes in manufacturing and marketing animal health products, mineral nutrition, and performance products across the globe. With..
Ardelyx, Inc. (NASDAQ: ARDX) is carving a niche in the biotechnology sector with its innovative therapies aimed at addressing unmet medical needs, and its financial metrics suggest a compelling opportunity..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a dynamic player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, has been catching the eye of investors seeking potential..
In the dynamic world of medical devices, InMode Ltd. (NASDAQ: INMD) stands out as a company that has carved a niche in the aesthetic healthcare market. Based in Israel, InMode..
Geron Corporation (NASDAQ: GERN) is capturing investor attention with a staggering potential upside of 185.85%, according to analyst estimates. This commercial-stage biopharmaceutical company, headquartered in Foster City, California, focuses on..
Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to cancer therapies. Based in Hayward, California, Arcus is focused..
Bridgepoint Group plc (LON:BPT) has announced interim results for the six months to 30 June 2025, with the Bridgepoint Group continuing to deliver strong financial performance. Thanks to continued good..
